GlobeNewswire

NeuroXen Editorial Report: “Strongest Adderall Alternative” Reflects Consumer Search Language in 2026 and Does Not …

Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong China market presenceNext-generation …

MESA, AZ, Jan. 14, 2026 (GLOBE NEWSWIRE) — MESA, AZ – January 15, 2026 – …

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) — ATLAS SP Partners (“ATLAS”), the warehouse finance …

NEW YORK, Jan. 13, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor …

NEW YORK, Jan. 12, 2026 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor …

Hong Kong, Jan. 12, 2026 (GLOBE NEWSWIRE) — Green Circle Decarbonize Technology Limited (the “Company” …

On February 4—in Las Vegas, at the National Automobile Dealers Association (NADA) Show — FF …

Richard Francis, Teva’s President and CEO, will present at the 44th Annual J.P. Morgan Healthcare Conference …

Earthing Sheets, Silver-Infused Organic Bedding, and Grounding Sleep Technology Examined — What Published Studies Show, …